SMECF Stock | News | Quote | Stock Forum | Sunday, October 13,

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

SUNON's Unique Spin on Future Workspaces The world of workplace solutions is buzzing with ideas on how to blend smart tech with soulful spaces. This year, SUNON is hitting ORGATEC 2026 in Cologne with a bold approach that stitches AI, nature, and circular design right into the fabric of office life. They’re not just setting up shop; they’re promising a peek into a...

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Palladius Capital Management Expands Its Investment Portfolio Palladius Capital Management, a renowned real estate investment manager, has made significant strides in the residential real estate sector. Recently, they announced the acquisition of nine residential real estate assets valued at $579 million. This impressive portfolio comprises five multifamily properties and...

Forza X1 Director Makes a Bold Move with Company Shares In an eye-catching development, Kevin Schuyler, a director at Forza X1, Inc. (NASDAQ:FRZA), has attracted attention with his recent purchase of $27,200 worth of company stock. Schuyler acquired an impressive 90,668 shares at a price of $0.30 each, which brings his total to 100,000 shares, as per the latest filings....

Whitlock Law Supports Community Events with Sponsorship Attorney Morgan Whitlock is thrilled to share that her firm, Whitlock Law, has stepped up to sponsor the Loudoun Pride Festival for 2025. As a Gold Sponsor, she has made a significant contribution to the festival, committing over $2,500 to help promote inclusivity and support for the LGBTQ+ community. About the...

Chaco Launches Designapalooza Contest for the Community Get ready for an exciting opportunity to unleash your creativity with Chaco's newest initiative, the Designapalooza contest. This competition invites artists and fans from all backgrounds to contribute their unique designs for a chance to shape the next iconic Z/1 Classic sandal strap. Not only does it encourage...

Renewal of Algoma Steel Group's Normal Course Issuer Bid Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) has revealed its intention to renew its normal course issuer bid (NCIB) for a portion of its common shares and warrants. This initiative is designed to be advantageous for the Company, allowing it to capitalize on fluctuations in market prices. Through this program,...